BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6167687)

  • 1. HLA-antigens and the prognosis of multiple sclerosis.
    Poser S; Ritter G; Bauer HJ; Grosse-Wilde H; Kuwert EK; Raun NE
    J Neurol; 1981; 225(3):219-21. PubMed ID: 6167687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.
    Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W
    Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and the response of lymphocytes to viral antigens in patients with multiple sclerosis.
    Walker JE; Cook JD; Harrison P; Stastny P
    Hum Immunol; 1982 Feb; 4(1):71-8. PubMed ID: 7061242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of HLA antigens in multiple sclerosis.
    Jersild C
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings.
    Söderström M; Ya-Ping J; Hillert J; Link H
    Neurology; 1998 Mar; 50(3):708-14. PubMed ID: 9521261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
    Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
    Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and Japanese MS.
    Naito S; Kuroiwa Y; Itoyama T; Tsubaki T; Horikawa A; Sasazuki T; Noguchi S; Ohtsuki S; Tokuomi H; Miyatake T; Takahata N; Kawanami S
    Tissue Antigens; 1978 Jul; 12(1):19-24. PubMed ID: 80838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.
    Hillert J; Käll T; Olerup O; Söderström M
    Acta Neurol Scand; 1996 Sep; 94(3):161-6. PubMed ID: 8899048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis.
    Brautbar C; Cohen I; Kahana E; Alter M; Jorgensen F; Lamm L
    Tissue Antigens; 1977 Oct; 10(4):291-302. PubMed ID: 72427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between HLA-Dw2 and multiple sclerosis in Israeli Jewish patients.
    Brautbar N; Lahana E; Alter M; Jorgensen F; Lamm L
    N Engl J Med; 1977 Jun; 296(26):1537-8. PubMed ID: 865542
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression.
    Duquette P; Décary F; Pleines J; Boivin D; Lamoureux G; Cosgrove JB; Lapierre Y
    Can J Neurol Sci; 1985 May; 12(2):106-10. PubMed ID: 3860275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.
    Paty DW; Dossetor JB; Stiller CR; Cousin HK; Marchuk L; Furesz J; Boucher DW
    J Neurol Sci; 1977 Jul; 32(3):371-9. PubMed ID: 886362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany.
    Poser S; Bauer HJ; Poser W
    Acta Neurol Scand; 1982 Apr; 65(4):347-54. PubMed ID: 7102261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.
    Miller DH; Hornabrook RW; Dagger J; Fong R
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):43-6. PubMed ID: 3457100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DW2, viral immunity and family studies in multiple sclerosis.
    Stewart GJ; Basten A; Guinan J; Bashir HV; Cameron J; McLeod JG
    J Neurol Sci; 1977 Jun; 32(2):153-67. PubMed ID: 874517
    [No Abstract]   [Full Text] [Related]  

  • 20. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families.
    Hillert J; Käll T; Vrethem M; Fredrikson S; Ohlson M; Olerup O
    J Neuroimmunol; 1994 Feb; 50(1):95-100. PubMed ID: 8300862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.